EBOLA VIRUS DISEASE
Clinical trials for EBOLA VIRUS DISEASE explained in plain language.
Never miss a new study
Get alerted when new EBOLA VIRUS DISEASE trials appear
Sign up with your email to follow new studies for EBOLA VIRUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Ebola shield: can a Vaccine-Antibody duo stop the virus?
Prevention Not yet recruitingThis study tests whether giving the Ervebo vaccine together with Inmazeb antibodies can safely prevent Ebola in healthy adults. The vaccine works slowly, while antibodies act fast, so researchers want to see if they interfere with each other. About 132 volunteers will receive dif…
Matched conditions: EBOLA VIRUS DISEASE
Phase: PHASE2 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Prevention
Last updated May 17, 2026 05:30 UTC
-
Ebola breakthrough? new trial aims to stop virus after exposure
Prevention Not yet recruitingThis study tests whether giving a combination of a vaccine (Ervebo) and an antibody drug (Inmazeb) right after exposure to Ebola can prevent the disease better than the vaccine alone. It involves 160 people who have had close contact with an Ebola patient, such as touching their …
Matched conditions: EBOLA VIRUS DISEASE
Phase: PHASE3 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Prevention
Last updated May 14, 2026 12:06 UTC